Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. more
Time Frame | SKIN | Sector | S&P500 |
---|---|---|---|
1-Week Return | 5.33% | -0.41% | -0.57% |
1-Month Return | -14.59% | 1.45% | 1.21% |
3-Month Return | 5.33% | -2.25% | 7.57% |
6-Month Return | -22.17% | 6.81% | 11.45% |
1-Year Return | -48.53% | 13.47% | 28.48% |
3-Year Return | -93.05% | 9.15% | 29.52% |
5-Year Return | -85.42% | 30.68% | 90.66% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 166.62M | 119.09M | 260.09M | 365.88M | 397.99M | [{"date":"2019-12-31","value":41.87,"profit":true},{"date":"2020-12-31","value":29.92,"profit":true},{"date":"2021-12-31","value":65.35,"profit":true},{"date":"2022-12-31","value":91.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 60.11M | 51.89M | 78.26M | 115.54M | 242.88M | [{"date":"2019-12-31","value":24.75,"profit":true},{"date":"2020-12-31","value":21.37,"profit":true},{"date":"2021-12-31","value":32.22,"profit":true},{"date":"2022-12-31","value":47.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 106.51M | 67.20M | 181.83M | 250.34M | 155.11M | [{"date":"2019-12-31","value":42.55,"profit":true},{"date":"2020-12-31","value":26.84,"profit":true},{"date":"2021-12-31","value":72.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":61.96,"profit":true}] |
Gross Margin | 63.92% | 56.43% | 69.91% | 68.42% | 38.97% | [{"date":"2019-12-31","value":91.44,"profit":true},{"date":"2020-12-31","value":80.71,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.87,"profit":true},{"date":"2023-12-31","value":55.75,"profit":true}] |
Operating Expenses | 93.05M | 84.38M | 218.47M | 274.62M | 286.03M | [{"date":"2019-12-31","value":32.53,"profit":true},{"date":"2020-12-31","value":29.5,"profit":true},{"date":"2021-12-31","value":76.38,"profit":true},{"date":"2022-12-31","value":96.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 13.46M | (17.18M) | (36.64M) | (24.28M) | (130.92M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-127.63,"profit":false},{"date":"2021-12-31","value":-272.17,"profit":false},{"date":"2022-12-31","value":-180.36,"profit":false},{"date":"2023-12-31","value":-972.49,"profit":false}] |
Total Non-Operating Income/Expense | (33.49M) | (42.58M) | (352.49M) | 66.96M | 38.55M | [{"date":"2019-12-31","value":-50.01,"profit":false},{"date":"2020-12-31","value":-63.58,"profit":false},{"date":"2021-12-31","value":-526.39,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":57.57,"profit":true}] |
Pre-Tax Income | (2.94M) | (38.48M) | (377.35M) | 45.03M | (101.89M) | [{"date":"2019-12-31","value":-6.52,"profit":false},{"date":"2020-12-31","value":-85.46,"profit":false},{"date":"2021-12-31","value":-837.96,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-226.26,"profit":false}] |
Income Taxes | (1.30M) | (9.31M) | (2.24M) | 648.00K | (1.77M) | [{"date":"2019-12-31","value":-200.15,"profit":false},{"date":"2020-12-31","value":-1436.42,"profit":false},{"date":"2021-12-31","value":-345.99,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-273.61,"profit":false}] |
Income After Taxes | (1.64M) | (29.18M) | (375.11M) | 44.38M | (100.12M) | [{"date":"2019-12-31","value":-3.69,"profit":false},{"date":"2020-12-31","value":-65.73,"profit":false},{"date":"2021-12-31","value":-845.14,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-225.57,"profit":false}] |
Income From Continuous Operations | (1.64M) | (29.18M) | (375.11M) | 44.38M | (100.12M) | [{"date":"2019-12-31","value":-3.69,"profit":false},{"date":"2020-12-31","value":-65.73,"profit":false},{"date":"2021-12-31","value":-845.14,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-225.57,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (1.64M) | (29.18M) | (375.11M) | 44.22M | (100.12M) | [{"date":"2019-12-31","value":-3.7,"profit":false},{"date":"2020-12-31","value":-65.97,"profit":false},{"date":"2021-12-31","value":-848.2,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-226.38,"profit":false}] |
EPS (Diluted) | - | (83.90) | (1.72) | 0.33 | 0.16 | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-25422.82,"profit":false},{"date":"2021-12-31","value":-521.21,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":48.48,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
SKIN | |
---|---|
Cash Ratio | 4.85 |
Current Ratio | 6.56 |
Quick Ratio | 5.57 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SKIN | |
---|---|
ROA (LTM) | -5.90% |
ROE (LTM) | -37.64% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SKIN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.91 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.09 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SKIN | |
---|---|
Trailing PE | NM |
Forward PE | 25.51 |
P/S (TTM) | 0.56 |
P/B | 3.28 |
Price/FCF | 24 |
EV/R | 1.17 |
EV/Ebitda | 18.63 |
PEG | 0.95 |
Beauty Health Co (SKIN) share price today is $1.58
Yes, Indians can buy shares of Beauty Health Co (SKIN) on Vested. To buy Beauty Health Co from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SKIN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Beauty Health Co (SKIN) via the Vested app. You can start investing in Beauty Health Co (SKIN) with a minimum investment of $1.
You can invest in shares of Beauty Health Co (SKIN) via Vested in three simple steps:
The 52-week high price of Beauty Health Co (SKIN) is $5.17. The 52-week low price of Beauty Health Co (SKIN) is $0.91.
The price-to-earnings (P/E) ratio of Beauty Health Co (SKIN) is
The price-to-book (P/B) ratio of Beauty Health Co (SKIN) is 3.28
The dividend yield of Beauty Health Co (SKIN) is 0.00%
The market capitalization of Beauty Health Co (SKIN) is $187.42M
The stock symbol (or ticker) of Beauty Health Co is SKIN